www.tickerreport.com ·
Zacks Research Analysts Reduce Earnings Estimates for Hain
Topic context
This topic has been covered 138208 times in the last 7 days across our monitored publishers.
The full article is on the original publisher site.
AI insight
AI-generatedThe article covers an earnings estimate revision for Hain Celestial Group, a natural and organic food company. The downward revision reflects weak revenue and profitability trends. The commercial mechanism is a margin squeeze from lower revenue and potential input cost pressures. Impact is company-specific, not sector-wide.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- Zacks Research lowered Q2 2027 EPS estimate for HAIN from $0.06 to $0.03.
- Consensus full-year EPS estimate is ($0.16) per share.
- HAIN reported Q2 2026 EPS of ($0.01), beating estimate of ($0.02).
- Revenue of $338.36M missed forecast of $341.99M.
- Stock price $0.78, market cap $70.33M, 52-week range $0.55-$2.17.
Weak revenue trend may persist; margin compression risk over 1-4 weeks.
Sign in to see all sector verdicts, full thesis and counter-argument debate.
Sector impact at a glance
- CONSUMER_STAPLESmid
- CONSUMER_STAPLESshort
Related stories
prnewswire.com
Fosun International Recognized on Fortunes 2026 Most Admired Chinese Companies List
prnewswire.com
Immunic Appoints Distinguished Biopharmaceutical Executive Erik Lundgren as Chief Executive Officer
manilatimes.net
Fosun International Recognized on Fortunes 2026 Most Admired Chinese Companies List
portal.sina.com.hk
Zealand Pharma to Present Data at the American Diabetes Associations 2026 Scientific Sessions
finanznachrichten.de